EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

eNAMPT is a plasma biomarker of COVID-19 severity and ARDS progression linked to increased immune effector cell expression

Jason Canizales Galaviz, Amir Khan, Bochra Tourki, Susannah Patarroyo-White, Nathan H Johnson iD, Alejandro Arjona, Christian Bime, Kenneth S Knox, Mehdi S Mirsaeidi, Brenda Juan Guardela iD, Jose D Herazo-Maya, Nancy G Casanova iD und 1 weitere

PLOS One · 03.11.2026 · 21 (11) · e0360244

DOI: 10.1371/journal.pone.0360244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 03.11.2026. Verfasst von Jason Canizales Galaviz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Inflammation Science and Systems Medicine, The Herbert Wertheim University of Florida Scripps Research Institute, Jupiter, Florida, United…. Hauptthemen laut MEDLINE: COVID-19, Respiratory Distress Syndrome, Cytokines, Nicotinamide Phosphoribosyltransferase. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NHLBI Division of Intramural Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The COVID-19 pandemic highlighted the critical unmet need for novel targets, biomarkers, and effective pharmacotherapies to reduce the severity/mortality of COVID pneumonia and progression to acute respiratory distress syndrome (ARDS). Extracellular NAMPT (eNAMPT) is a druggable DAMP and TLR4 ligand centrally involved in ARDS pathobiology. We explored the utility of plasma eNAMPT measurements as a potential COVID-19 biomarker linked to ARDS progression and disease severity and investigated the potential cellular source for eNAMPT release/secretion in COVID-19 subjects.

Methods

A plasma biomarker panel of inflammatory cytokines (IL-1β, IL-6, IL-8, IL-1RA, TNF-α), DAMPs (eNAMPT, MIF) and vascular proteins (ANG-2, PSGL-1) were evaluated in three distinct COVID-19-positive cohorts (Miami, Arizona, Tampa) (n = 277) and healthy control subjects (n = 214). Single-cell RNA sequencing (scRNA-seq) publicly available on peripheral blood mononuclear cells (PBMCs) in a subset of Tampa COVID-19 survivors (n = 18) and an autopsied COVID lung tissue database was separately analyzed for biomarker gene expression.

Results

Plasma biomarkers, including eNAMPT were significantly elevated in COVID-19 subjects compared to healthy controls (p < 0.0001), with IL-1RA, IL-6 and eNAMPT exhibiting the strongest diagnostic performance. Biomarker levels (all except IL-8, MIF) were higher in COVID-19 ARDS cases vs COVID-19 pneumonia (n = 154, AUC 0.71–0.79, p < 0.05) and were significantly elevated in COVID non-survivors (IL-6, IL-1RA, TNF-α, eNAMPT, ANG-2, PSGL-1) compared to survivors (p < 0.05). NAMPT gene expression was significantly upregulated in COVID-19 PBMCs compared with healthy controls, most evident within the CD14 + monocyte cluster. Relative to lung tissue from non-COVID-19 infected, NAMPT gene expression was increased in specific COVID-19 lung cell populations, including neutrophils, CD16 + monocytes, conventional dendritic cells (cDCs), fibroblasts, endothelium, and alveolar macrophages.

Conclusion

Our study corroborated the utility of this biomarker panel for diagnostic and severity assessment in COVID-19- associated ARDS and as a strategy for subject stratification in therapeutic trials of eNAMPT-neutralizing therapies. We further identified NAMPT expression in immune effector cells that correlates with COVID-19 severity and lethality. Together, these findings suggest NAMPT plays a key role in sustaining inflammatory activation and impairing lung regeneration in fatal COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Respiratory Distress SyndromeCytokinesNicotinamide PhosphoribosyltransferaseHumansBiomarkersFemaleMaleSARS-CoV-2Middle AgedDisease ProgressionAdultSeverity of Illness IndexLeukocytes, MononuclearPandemics

Substanzen

BiomarkersCytokinesNicotinamide Phosphoribosyltransferasenicotinamide phosphoribosyltransferase, human

Autor:innen und Institutionen

  • Center for Inflammation Science and Systems Medicine, The Herbert Wertheim University of Florida Scripps Research Institute, Jupiter, Florida, United States of America.
  • Division of Pulmonary, Critical Care and Sleep Medicine. Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Ubben Center for Pulmonary Fibrosis Research, Tampa, Florida., United S…
  • University of Arizona College of Medicine, Phoenix, Arizona, United States of America.
  • Division of Pulmonary, Critical Care and Sleep Medicine, University of Texas at Austin, Austin, Texas.United States of America.

ORCID-Profile: Nathan H Johnson, Brenda Juan Guardela, Nancy G Casanova

Förderung

  • NHLBI NIH HHS
  • NHLBI Division of Intramural Research

Zitieren

APA

Canizales Galaviz, J., Khan, A., Tourki, B., Patarroyo-White, S., Johnson, N. H., Arjona, A., Bime, C., Knox, K. S., Mirsaeidi, M. S., Juan Guardela, B., Herazo-Maya, J. D., Casanova, N. G., & Garcia, J. G. N. (2026). eNAMPT is a plasma biomarker of COVID-19 severity and ARDS progression linked to increased immune effector cell expression. PLOS One, 21(11), e0360244. https://doi.org/10.1371/journal.pone.0360244

Vancouver

Canizales Galaviz J, Khan A, Tourki B, Patarroyo-White S, Johnson NH, Arjona A, et al. eNAMPT is a plasma biomarker of COVID-19 severity and ARDS progression linked to increased immune effector cell expression. PLOS One. 2026;21(11):e0360244. doi:10.1371/journal.pone.0360244

BibTeX
@article{CanizalesGalaviz2026,
  author = {Canizales Galaviz, Jason and Khan, Amir and Tourki, Bochra and Patarroyo-White, Susannah and Johnson, Nathan H and Arjona, Alejandro and Bime, Christian and Knox, Kenneth S and Mirsaeidi, Mehdi S and Juan Guardela, Brenda and Herazo-Maya, Jose D and Casanova, Nancy G and Garcia, Joe G N},
  title = {eNAMPT is a plasma biomarker of COVID-19 severity and ARDS progression linked to increased immune effector cell expression},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0360244},
  doi = {10.1371/journal.pone.0360244}
}
Kostenlos starten →